We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Lincoln Pharmaceuticals has reported a net profit of Rs 9.23 crore for the Q4FY20 ended March 2020 as against a net profit of Rs 7.17 crore in the corresponding period last year, a growth of 28.69 per cent.